Monday, June 12, 2006

Lilly diabetes drug shows promise |

Lilly diabetes drug shows promise |
It seems Eli Lilly and Company is bringing a ray of hope to diabetics. They have developed a new drug, Arxxant, that could help diabetics to reduce eye damage and perhaps avoid costly and painful laser eye surgery.

The new drug acts to inhibit damage to the eyes by enzymes. This deterioration is known as diabetic retinopathy. It was on the top of my diabeitc counselors list of worries for though us of newly introduced to the disease.

The treatment is as simple as taking a pill, and the study shows it less likely to cause side effects than a sugar pill. There appears to be no concerns with blood sugar levels nor blood pressure related to its use.

FDA review is normally one year, but due to Arxxant being the first drug to treat this diabetic issue. This would possibly reduce that review down to six months.

Please take a few moments to read the article at the link above.

No comments: